Sv
Da
En
Fr
De
Deal History
Om oss
Om oss
Team
Våra kontor
Globalscope
Newsletter
Services
Corporate Finance
Skuldrådgivning
Equity Research
Tillväxtkapital
IPO Advisory
Industries
Företagstjänster
Internet och konsumentprodukter
Industri och verkstad
Sjuk- och hälsovård
Mjukvara och TMT
Research
Analysmaterial
Makro och marknad
Career
Events
Insights
News
Bolagsnyheter
Deal News
I pressen
Newsletter
Kontakt
Newsletter
Sv
Da
En
Fr
De
Main menu button
Worldwide
Worldwide
Canada
Denmark
France
Germany
Poland
Sweden
United Kingdom
USA
Team
Deals
Kontakt
Worldwide
Worldwide
Canada
Denmark
France
Germany
Poland
Sweden
United Kingdom
USA
Aktieanalys
Team
Deals
Kontakt
Nyheter
Alla
Abera Bioscience
Adventure Box
Adverty
All for One Group
ALM Equity
Alzecure Pharma
Alzinova
Angler Gaming
Arctic Minerals
BellPal Holding
Bentley Endovascular Group
Biosergen
Biovica
Boozt
Candles Scandinavia
Cantargia
Carlsquare
CellaVision
CombiGene
CSAM Health Group
DanCann Pharma
Ecoclime
edyoutec
Elicera Therapeutics
Enrad
Fable Media
Frequentis
FRISQ
Future Gaming
GHP Specialty Care
GIAB
Gubra
H&D Wireless
Hansa Biopharma
Hanza
Herantis Pharma
InCoax
Kancera
Medclair Invest
Medivir
Midsummer
Mindark PE
Modus Therapeutics
Moninvent
NeoDynamics
Nexam Chemical
Nischer Properties
Nodebis
Nosa Plugs
Observit
Orion Corporation
Pharmiva
Prolight Diagnostics
Raytelligence
Risk Intelligence
SBB i Norden
Sensec
Spotlight Group
Svenska Aerogel
Teneo AI
Thinc Jetty
Viva Wine Group
Ytrade Group
Zazz Energy
Zinzino
Alla
Analysmaterial
Bolagsnyheter
Deal News
Events
I pressen
Insights
Makro och marknad
16 sep 2024
Carlsquare Equity Research: Swedish consumer sector snapshot
Analysmaterial
Viva Wine Group
12 sep 2024
Research update Biosergen: First patient treated in phase Ib study a success
Analysmaterial
Biosergen
11 sep 2024
Carlsquare weekly market letter: How to deal with a stormy market
Analysmaterial
Carlsquare
09 sep 2024
Equity Research Svenska Aerogel, Q2 2024: Low revenues, but important orders in place
Analysmaterial
Svenska Aerogel
09 sep 2024
Analys Svenska Aerogel, kv2 2024: Låg omsättning, men viktiga kundorder på plats
Analysmaterial
Svenska Aerogel
05 sep 2024
Analys Zinzino: Het sensommar
Analysmaterial
Zinzino
04 sep 2024
Carlsquare weekly market letter: Time for a new bump in the road?
Analysmaterial
Carlsquare
03 sep 2024
Analys Enrad, kv 2024: Enrad behöver satsa på växande marknader
Analysmaterial
Enrad
02 sep 2024
Analys Zinzino, kv2 2024: Bra vinsttillväxt trots lägre bruttomarginal
Analysmaterial
Zinzino
30 aug 2024
Analys Enrad, kv2 2024: Mycket starkt kvartal
Analysmaterial
Enrad
30 aug 2024
Analys Zinzino, kv2 2024: Vinsttillväxt trots pressad bruttomarginal
Analysmaterial
Zinzino
30 aug 2024
Analys Abera kv2 2024: Start av influensaprojekt i nytt labb
Analysmaterial
Abera Bioscience
29 aug 2024
Analys Svenska Aerogel, kv2 2024: Nettoomsättning under förväntan, men förbättrad lönsamhet
Analysmaterial
Svenska Aerogel
29 aug 2024
Equity Research Svenska Aerogel, Q2 2024: Net revenues below expectations, but better profitability
Analysmaterial
Svenska Aerogel
29 aug 2024
Equity research Viva Wine Group: Profitability uptick ahead of expectations
Analysmaterial
Viva Wine Group
29 aug 2024
Equity research Nosa Plugs Q2, 2024: A second quarter with significant news flow
Analysmaterial
Nosa Plugs
28 aug 2024
Equity research Viva Wine Group: Return to strong EBITA growth in Q2 2024
Analysmaterial
Viva Wine Group
28 aug 2024
Analys edyoutec, kv2 2024: Lönsamheten förbättras
Analysmaterial
edyoutec
28 aug 2024
Carlsquare weekly market letter: Does the Fed know something we don't?
Analysmaterial
Carlsquare
27 aug 2024
Analysuppdatering Fable Media, kv2 2024: Rekordkvartal ger uppsida i Fable Media
Analysmaterial
Fable Media
1
2
3
…
70
